Cytoarchitectural abnormalities have been described in the prefrontal cortex (PFC) of subjects with psychiatric disorders. We explored the possible genetic causalities that may underlie the cytoarchitectural abnormalities of calbindin-containing c-aminobutyric acid (GABA)ergic neurons and perineuronal oligodendrocytes in the PFC of subjects with psychiatric disorders by converging results from genome-wide single-nucleotide polymorphism (SNP) scans for the traits and expression SNP (eSNP) associations. In the initial genome-wide scans, we identified several development-and apoptosis-related genes associated with the cytoarchitectural traits. Moreover, the susceptibility gene for bipolar disorder, PPP2R2C, was found to be associated with the number of perineuronal oligodendrocytes. Further eSNP analyses indicated that two novel candidate genes, RAB2A and SLC38A1, were associated with the density of calbindinpositive neurons and the number of perineuronal oligodendrocytes, respectively. Our findings may provide novel insights into the genetic causalities associated with cytoarchitectural abnormalities in the PFC of subjects with major psychiatric disorders as well as into the etiology of such disorders.
Introduction
Reduced density of calbindin-containing g-aminobutyric acid (GABA)ergic interneurons 1 and reduced numbers of oligodendrocytes associated with a pyramidal neuron 2 have been described in the prefrontal cortex (PFC) of the major psychiatric disorders, schizophrenia, bipolar disorder, and depression. In a previous study, we identified potential molecular mechanisms that may underlie these abnormalities using correlation analyses between genome-wide expression profiles and the cytoarchitectural traits. 3 Although we determined that neurodevelopmental deficits and apoptosis are likely to contribute to these cytoarchitectural abnormalities, [3] [4] [5] the genetic causalities remain to be determined.
In the mouse brain, striatal neuronal number is heritable and the phenotypic variance is significantly explained by genetic variation, 6 suggesting that cell density in the human brain may also be heritable. Genome-wide association studies provide an unbiased approach to identifying genetic causalities associated with complex biological traits such as cytoarchitecture; however, because of sample availability and technical limitations, it is very difficult to obtain a large enough sample size in human postmortem studies. To overcome these limitations, we used an integrative approach that merged results from genome-wide single-nucleotide polymorphism (SNP) scans for the cytoarchitectural trait and cis expression SNP (eSNP) associations. The differential expression of genes is highly heritable, and cis and trans associations of gene expression regulation have been identified by genome-wide association studies in humans. [7] [8] [9] The identification of cis association of an SNP with gene expression levels leads to identification of reliable candidate genes for complex traits mapped to the same chromosomal locations. 10 Using public databases that contain genome-wide, high-throughput data sets and biological traits from the same subjects allows researchers to explore molecular mechanisms and genetic causalities underlying biological traits without time-consuming and labor-intensive benchwork. 3, 11 The Stanley Medical Research Institute database (SMRIDB, http:// www.stanleyresearch.org/brain/) includes cytoarchitectural data sets from several brain regions of subjects in the Stanley Neuropathology Consortium (SNC). Moreover, microarray expression data from multiple independent studies 12 using both the SNC samples and an additional cohort, the Array Collection (AC), are available in the same database. In this study, we explore the possible genetic causalities that may underlie the cytoarchitectural traits of density of calbindin-containing GABAergic neurons and number of perineuronal oligodendrocytes in the PFC using genome-wide SNP chip data, expression profiles and cytoarchitectural data downloaded from the SMRIDB.
Materials and methods

Data used in this study
The cytoarchitectural data, such as density of calbindincontaining GABAergic neurons and number of perineuronal oligodendrocytes, were generated by two independent groups using samples from the SNC (N = 60), which contains 15 well-matched cases in each of the following four groups: schizophrenia, bipolar disorder, major depression and unaffected controls. 13 These groups are matched for descriptive variables such as age, gender, race, post-mortem interval, mRNA quality, brain pH and hemisphere. The data were downloaded from the SMRIDB (http://www.stanleyresearch.org/brain/), and then examined to determine whether the cytoarchitectural traits were distributed normally by using the Kolmogorov-Smirnov test with Lilliefors adjusted Pvalue (Statistica, StatSoft, Tulsa, OK, USA). As the number of perineuronal oligodendrocytes deviated from normal distribution, log transformation was conducted for further SNP association studies.
Microarray gene expression data from the SNC and AC (N = 105) were used in this study. The AC is an independent tissue collection containing 35 cases in each of the following three groups: schizophrenia, bipolar disorder and unaffected controls. MAS5-normalized microarray data from four independent studies were downloaded from the SMRIDB and then used for the eSNP association study. Only microarray data using the Affymetrix Human Genome (Santa Clara, CA, USA) U133 Set A (HGU133A) chips were used to avoid variations from different platforms.
A total of 97 chips from 42 bipolar disorder patients, 9 chips from 9 depression patients, 104 chips from 43 schizophrenia patients and 107 chips from 44 unaffected controls were used for the eSNP association analyses. Outlier chips were excluded in this analysis based on previous quality control analyses for chip level parameters such as scaling factor, gene call and average correlation. 12 Seven ethnic outlier cases were excluded based on the pairwise identity-by-state analysis as described below. One additional sample from AC was excluded because of a final diagnosis of cerebral autosomaldominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Chips from the same individual were treated as technical replicates.
The SNP genotyping data were generated by Dr Liu and colleagues using Human SNP Array 5.0 chips (Affymetrix). DNA samples from SNC and AC were used for the study. Raw cel files from the original study are also available from the SMRIDB.
Biological and clinical variables of samples used for association studies are listed in Supplementary Table 1 .
Association analysis
Raw image files from SNP chips (N = 164) using SNC and AC samples were imported into the Affymetrix Genotyping Console (Affymetrix) and followed by quality control analysis and gender checks. All samples passed the gender checks. The default thresholds for quality control call rates (X86%) were used. Genotypes were called using the BRLMM algorithm (Affymetrix). SNPs with a call rate of < 90%, minor allele frequency below 5% or extreme deviation from Hardy-Weinberg equilibrium test (P < 0.05) were filtered out for further association study. A total of 309 531 SNPs passed this filter. For examination of population stratification, clustering was initially performed using the pairwise identityby-state calculator in the PLINK.
14 Identity-by-state pairwise distances were then plotted and examined by multidimensional scaling analysis and Z-statistical analysis. Samples of more than three s.d. compared with the group mean were considered outliers. Population stratification was further examined during the association analyses. Genomic inflation factors based on median w 2 were calculated and the quantilequantile plot of the observed P-value distribution vs the expected P-value distribution for each trait was generated using PLINK and Haploview. 15 
Cytoarchitectural traits
Two cytoarchitectural traits in the PFC-density of calbindin-containing GABAergic neurons and number of perineuronal oligodendrocytes-were generated by two independent groups 1,2 Briefly, 10 mmthick paraffin sections of the PFC (BA9) were used to stain calbindin-containing GABAergic neurons. Two sections from each case, at least 50 mm apart, were analyzed. The density of the neurons was counted from a total of ten 500 mm-wide cortical traverses and expressed as mean number of cells per mm 2 per cortical layer. 1 Ten paraffin sections per case of PFC (BA9) were used for counting the number of perineuronal oligodendrocytes. 2 Oligodendrocytes located within a distance of 5 mm from a neuron were counted after Nissl staining. Oligodendrocytes were identified by their characteristic morphology, including a small round or oval nucleus with relatively dense nuclear staining and a narrow unstained rim of the cytoplasm. 2 The genome-wide association analyses for the cytoarchitectural traits were performed using a multiple linear regression model with covariates. A correlation test was conducted to examine the association between the clinical variables-age of onset and antipsychotic treatment-and the traits (StatView, SAS, Cary, NC, USA). Although there was no significant correlation between either of the clinical variables and the density of calbindincontaining GABAergic neurons, the two variables were both significantly correlated with the number of perineuronal oligodendrocytes (all P < 0.01).
Moreover, as age and sex have both been associated with the etiology of neuropsychiatric disorders and with the complex traits related to those disorders, we used a linear model with or without age and sex as covariates for the association analyses. Thus, a linear model with no covariates or with age and sex as covariates was used for the association analysis of the density of calbindin-containing GABAergic neurons. For the number of perineuronal oligodendrocytes, the linear model included age of onset and antipsychotic treatment as covariates or the model included age, sex, age of onset and antipsychotic treatment as covariates. Nominal P-values < 1E-04 were considered significant for the initial genome-wide scans. This criteria is used for genome-wide association studies for complex traits, especially if there are multiple biological evidences for supporting candidate genes or further functional annotation analysis that support the candidate genes [16] [17] [18] The linked genes and minor allele frequencies of the significant SNPs in the Centre Etude Polymorphism Humain (CEPH) samples (Utah residents with ancestry from northern and western Europe) were obtained using NetAffx (http://www.affymetrix.com/analysis/index.affx).
Differentially expressed genes were selected for the association analysis of the traits to reduce the number of multiple tests as highly differentially expressed genes are more likely to be associated with complex traits. 19 Batch effect and brain pH-adjusted microarray data were used for selecting highly differentially expressed genes. The normalization process and adjustment method for the microarray data are described in the following section. Low-variance genes were filtered out using a fold-change filter if < 30% of the expression data values had at least a 1.5 fold change in either direction from the gene's median value or the log intensity variation filter (P > 0.01). In addition, genes with > 5% of data absent were filtered out. A total of 325 genes passed this filtering process (Supplementary Table 2 ). The SNPs within the filtered genes were selected using PLINK and were used for further association analyses of the cytoarchitectural traits.
Gene expression in the PFC. Microarray gene expression data from the four independent studies were initially adjusted for brain pH and batch effect using ComBat, 20 because brain pH significantly affects mRNA levels in post-mortem brain tissues 21 and batch effects have been shown to significantly contribute to variations in expression profiles in multiple microarray data sets. 20 Adjusted microarray data were then imported into and further processed with the biometric research branch (BRB)-array tools (http://linus.nci.nih.gov/BRB-ArrayTools.html). After median normalization, expression levels of the 47 probe sets (28 genes) associated with significant SNPs from the genome-wide scans for the cytoarchitectural traits were exported using BRB-array tool and used as trait data in PLINK. Significant SNPs were annotated using NetAffx. We defined cis eSNPs as those SNPs that were localized within 1 Mb of either the 5 0 or the 3 0 end of the gene. We used false discovery rate adjustment for corrections for multiple testing (PLINK). False discovery rateadjusted P-values < 0.01 were considered significant for the confirmative eSNP associations.
Results
Genome-wide associations of the cytoarchitectural traits An integrative, genome-wide association analysis was performed to identify the genes that may contribute to the density of calbindin-containing GABAergic neurons or to the number of perineuronal oligodendrocytes. First, we detected ethnic outlier samples using Z-scores derived from identity-by-state information. Four outliers from the SNC samples and three outliers from the AC samples were excluded, based on the Z-scores ( > |3|), from further SNP association analyses (Supplementary Table 3 ). The ethnic outliers were from non-Caucasian populations and were consistent with our demographic information. A total of 309 531 SNPs passed our quality control filters (see Materials and methods) and were included in the genome-wide scans for possible association with the density of calbindin-containing GABAergic neurons and the number of perineuronal oligodendrocytes in the SNC samples (n = 56). A genome-wide scan for each cytoarchitectural trait was conducted using a linear regression model with covariates. Forty-nine SNPs were significantly associated with the density of calbindin-containing GABAergic neurons with nominal P-values < 1E-04 from a genome-wide scan using a linear regression model with age and sex as covariates (Table 1) . Twenty genes are linked to the SNPs, including cell growth-, apoptosis-and development-related genes such as SOX11, MCC, HDAC9 and RAB2A. Thirty-nine SNPs were significantly associated with the number of perineuronal oligodendrocytes with nominal P-values < 1E-04 from a genome-wide scan using a linear regression model with age, sex, age of onset and antipsychotic treatment as covariates (Table 2) . Thirty-one genes were associated with these SNPs (Table 2) , including several apoptosis, cell growth or cell-cell adhesion genes (PPP2R2C, SGMS2, PCDH10, ENC1, GRIK2, SLC38A1 and NCAM2). Minor allele frequencies of the significant SNPs in our samples were similar to those from the CEPH population (Tables 1 and 2 ). We also used a linear regression model excluding age and sex as covariates. This modeling yielded similar significant SNPs to those from the association analysis with age and sex as covariates (Supplementary Tables 4 and 5) .
However, as the SNPs in Tables 1 and 2 did not reach significance level of P < 0.05 after adjustment for multiple testing, we performed an association analyses with prioritized SNPs. A total of 3469 SNPs are within highly differentially expressed genes. Although none of the SNPs were significantly associated with the number of perineuronal oligodendrocytes, six SNPs within RAB2A were significantly associated with the density of calbindin-containing GABAergic neurons with false discovery rate P-values at 0.05. Those SNPs are rs595255, rs2930040, rs12681129, rs41420549, rs2981277 and rs7013249.
Genome-wide cis associations of expression levels of the cytoarchitectural trait candidate genes An eSNP association analysis of the candidate genes from Tables 1 and 2 was conducted using our P-values were derived from a genome-wide scan for the trait (in the Stanley Neuropathology Consortium (SNC) collection; N = 56) using a multiple regression model with age and sex as covariates, whereas MAF a was determined in the combined collection (SNC and Array Collection; N = 157). The genes linked to the SNPs and MAF b of the significant SNPs in CEPH samples (Utah residents with ancestry from northern and western Europe) were obtained using NetAffx (http:// www.affymetrix.com/analysis/index.affx). extended data set (N = 138). In eSNP association studies, genome-wide expression profiles should be robust and derived from a tissue relevant to the trait in order to identify candidate genes for a complex trait. 10 Most previous eSNP association studies used samples from unaffected controls; 7-9 however, our cohort includes case and control samples. Thus, to assess the effect of including cases and controls in the analysis, we first attempted to replicate the cis eSNPs of seven genes that were previously identified in the normal human cortex 8 and that were also in our data set. We replicated the cis associations between expression levels of HBS1L, ZNF419 and RPS26, and SNPs within 1 Mb of the genes (Table 3) . Minor allele frequencies of the significant SNPs in our samples were similar to those from the CEPH population (Table 3) . We therefore validated our approach by replicating the previous cis eSNP associations.
We then tested the cis SNP associations with the expression levels of 47 probe sets of 28 genes on the HGU133A chip from Tables 1 and 2 (Supplementary  Table 6 ). A significant cis SNP association was identified for the expression level of RAB2A, which was identified as a candidate gene from our initial genome-wide scan for the calbindin-containing GABAergic neuron, with nominal P-value 2.57E-28 (rs9437; adjusted P = 7.96E-23; Figure 1) . A significant P-values were derived from a genome-wide scan for the trait (in the Stanley Neuropathology Consortium (SNC) collection; N = 56) using a multiple regression model with age, sex, age of onset and antipsychotic treatment as covariates, whereas MAF a was determined in the combined collection (SNC and Array Collection; N = 157). The genes linked to the SNPs and MAF b of the significant SNPs in CEPH samples (Utah residents with ancestry from northern and western Europe) were obtained using NetAffx (http://www.affymetrix.com/analysis/index.affx). was determined in the combined collection (the Stanley Neuropathology Consortium and Array Collection; N = 157), and MAF c of the SNPs in CEPH samples (Utah residents with ancestry from northern and western Europe) were obtained using NetAffx (http://www.affymetrix.com/analysis/index.affx). P-values of the most significant cis eSNPs were derived from genome-wide scans using MAS5-normalized expression levels as traits. -log 10 (P) Figure 1 Genome-wide single-nucleotide polymorphism (SNP) association analyses for expression levels of the two candidate genes, RAB2A (a) and SLC38A1 (b), which were associated with the density of calbindin-positive g-aminobutyric acid (GABA)ergic neurons and the number of perineuronal oligodendrocytes, respectively.
cis SNP association was also identified for the expression level of SLC38A1, a candidate gene from the genome-wide scan for the number of perineuronal oligodendrocytes, with a nominal P-value 5.48E-12 (rs1492890; adjusted P = 1.14E-06; Figure 1 ). As ethnicity significantly affects eSNP associations, 22 unadjusted population stratification may cause false-positive association or false-negative association. Thus, we further examined population stratification or cryptic relatedness in our samples using genomic inflation factor and quantile-quantile plot. Genomic inflation factors for expression of RAB2A and SLC38A1 were 1 and 1.0179, respectively, providing little evidence of population stratification. In addition, quantile-quantile plots provide little possibility of false-positive associations with the traits because of population stratification (Supplementary Figure 1) .
To estimate the detection power of our association study for the gene expression traits, we conducted a power analysis using Quanto software. 23 Because the effect sizes of the two candidate genes, RAB2A and SLC38A1, were large, with R 2 = 0.59 and 0.30, respectively, our sample size (N = 138) had > 90% power to detect the association for the two gene expression traits at a = 1.6E-07, which is the type I error rate of 5% corrected for a total of 309 531 tests performed in the eSNP association analysis.
To replicate our cis eSNP association in an independent sample, we queried results from an eSNP association analysis of the two candidate genes using the SNPExpress database. 24 Although a significant cis eSNP association of RAB2A was absent, there was a significant cis association between the expression level of the last exon probe of SLC38A1 in the brain and an SNP within the gene (rs2279560; unadjusted P-value 8.45E-9) (Supplementary Figure 2) . Furthermore, a significant cis association between the same SNP identified in this study and the expression level of SLC38A1 was also replicated in another independent cortical sample (rs1492890; unadjusted P-value 1.20E-15). 8 
Discussion
Neurodevelopmental deficits have been proposed as a mechanism that may underlie the cytoarchitectural abnormalities observed in psychiatric disorders, including schizophrenia. 4 Our previous study revealed that the expression level of genes in biological processes related to the central nervous system development and apoptosis was significantly associated with the density of calbindin-containing GABAergic neurons and with the number of perineuronal oligodendrocytes in the PFC of subjects with major mental disorders. 3 In this study, we explored the genetic causalities underlying those cytoarchitectural traits using an integrative SNP association analysis. Initially, we conducted genome-wide SNP association scans for the two cytoarchitectural traits. We then examined the cis SNP associations of the expression levels of the candidate genes obtained from the initial scans. The small effect size of each genetic locus in psychiatric disorders suggests that the causal genetic variations may regulate gene expression levels rather than result in protein coding sequence variation. 25 Hence, examination of cis eSNP associations within the candidate genes is a reliable approach for identification of strong candidate genes for complex traits.
The most important finding to emerge from this study is the identification of two novel candidate genes, RAB2A and SLC38A1, associated with the density of calbindin-containing GABAergic neurons and the number of perineuronal oligodendrocytes in the PFC, respectively. We found seven SNPs in the RAB2A gene (all P < 8.99E-05) associated with the cytoarchitectural trait as well as a significant cisassociated eSNP in the 3 0 region of the gene (P = 2.57E-28; adjusted P = 7.96E-23). Furthermore, a total of six SNPs in the genes were significantly associated with the cytoarchitectural trait in the association analysis with the prioritized SNPs (false discovery rate adjusted P = 0.05). The functional role of the SNP on RAB2A mRNA levels will need to be determined by further experiments. RAB2A is a small GTP-binding protein of the Ras superfamily that has a role in membrane fusion and trafficking. Although the exact biological function of RAB2A is not known in mammals, a recent study in Caenorhabditis elegans suggests that Rab2 protein is involved in regulation of locomotor activity and apoptosis depending on the cell type. 26 Apoptosis was one of the main processes associated with the density of calbindin-containing GABAergic neurons in our previous correlation analysis. 3 Akt1 mRNA and protein levels and MAPK1 mRNA levels were positively correlated with the density of calbindin-containing GABAergic neurons in our previous study, suggesting that deficits in Aktmediated antiapoptotic activity may be associated with the cytoarchitectural abnormality in psychiatric disorders. 3 It remains to be determined whether differential expression of RAB2A affects synaptic vesicle transport or protein transport in GABAergic neurons. However, our previous and current findings, together with previous results concerning the role of RAB2, 27 suggest that differential expression of RAB2A may be involved in deficits of vesicle transport, neurotransmitter release or protein transport that eventually promote apoptosis of the calbindin-containing GABAergic cells by inhibiting anti-apoptotic pathways such as the Akt-mediated pathway. In fact, biological processes related to vesicle-mediated transport and protein transport were highly overrepresented in the list of genes correlated with the density of calbindin-containing neurons in our previous study.
post-mortem brain, 8, 24 thus increasing the possibility of a true association between cis SNP and expression levels of this gene in the brain. SLC38A1 (solute carrier family 38, member 1) encodes a sodiumcoupled neutral amino-acid transporter that transports glutamine into the neurons and glial cells. SLC38A1 is localized to both GFAP-positive and -negative cells in the white matter of the human cortex. However, although there is currently no evidence from electron microscopy of the rat cortex that these white matter cells are oligodendrocytes, 28 the study has yet to be carried out in the human. Transported glutamine is used as a precursor of glutamate, a major excitatory neurotransmitter, which mediates synaptic transmission, plasticity and neurotoxicity in the central nervous system. 29 Overactivation of N-methyl-D-aspartate-type glutamate (NMDA) receptors results in calcium influx into the neurons and induces oxidative stress in cells by overloading calcium in the mitochondria and by inducing abnormal energy metabolism and excess reactive oxygen species, which eventually leads to cell death. 30, 31 Although this process is mainly known to occur in the neurons, the presence of the NMDA receptors on oligodendrocytes suggests that they may have a similar role in apoptotic processes in oligodendrocytes. 32, 33 However, the possibility of a-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate (AMPA)/ kainate receptor-mediated excitotoxicity in oligodendrocytes cannot be ruled out. Cultured oligodendrocytes were killed by AMPA, kainate and glutamate. 34 Moreover, our previous study revealed that metabolic pathways related to mitochondria were significantly overrepresented in the genes correlated with the number of perineuronal oligodendrocytes. Although we cannot rule out oligodendrocyte death by a direct metabolic disturbance of the glutamate-glutamine pathway, these results suggest that differential expression of SLC38A1 may result in deficits in glutamine-glutamate metabolism, which eventually may lead to cell death by NMDA and/or AMPA/ kainite receptor-mediated cytotoxicity.
Previous association studies have shown that cis and trans eSNPs have a significant role in the regulation of gene expression in humans. [7] [8] [9] Most previous studies used viral-transformed lymphoblastoid cell lines from unaffected subjects. However, a recent study showed that more expression profiles were correlated with obesity-related clinical traits in adipose tissues than in blood cells. 10 Thus, it may be crucial to use expression profiles from tissues relevant to traits of interest when identifying candidate causalities from eSNP association analysis. In this study, we used gene expression profiles of the PFC from unaffected subjects as well as from patients with major psychiatric disorders as traits for the eSNP association analyses. We also examined the cis associations of seven genes from a previous eSNP association study in which gene expression levels were measured from the cerebral cortex of unaffected subjects. 8 We replicated the cis eSNPs association of three genes out of the seven. The cis eSNP associations of our candidate gene, RAB2A, was not found in the previous study, which implies that although eSNP association studies using tissues from unaffected subjects may potentially identify candidate genes that cause complex traits, more direct evidence for association between gene expression and complex traits may be derived from using relevant tissue from disordered cases and unaffected controls. Our initial genome-wide SNP association scan for the number of perineuronal oligodendrocytes yielded a previously identified susceptibility gene for bipolar disorder (PPP2R2C). 35 However, there was no significant association between the cis SNPs and the expression level of the gene in the SNPExpress database, 24 and we were unable to confirm the SNP association in our samples, as the gene is absent from our expression microarray data set. Nevertheless, deficits in oligodendrocytes have been identified as a significant neuropathology in schizophrenia and in bipolar disorder, 36, 37 and genome-wide expression profiling revealed that oligodendrocyte-related genes are downregulated in the PFC of both schizophrenia and bipolar disorder. [38] [39] [40] The findings from the genome-wide scan will need to be replicated by an independent association study with a larger sample size; however, the preliminary findings support the hypothesis that developmental deficits of oligodendrocytes may contribute to the etiology of major psychiatric disorders such as schizophrenia and bipolar disorder.
Although this study provides interesting novel insights into the possible genetic causalities underlying the cytoarchitectural abnormalities in the PFC of major psychiatric disorders, there are several limitations. First, we used a relatively small sample size, which is known to cause higher false-positive associations in genome-wide association studies. In our initial genome-wide scans for the cytoarchitectural traits, none of the SNPs reached genome-wide significance level. We therefore used an integrative approach to overcome this limitation. A power analysis indicated that our sample size (N = 138) was enough to detect associations for gene expression traits with large effect size (R 2 > 0.3). Moreover, a previous eSNP association study suggests that a relatively small sample size (N = 100) has > 80% power to detect association of gene expression traits with high effect size (R 2 = 0.35). 41 In most previous genome-wide association studies for psychiatric disorders, only a few SNPs reach genome-wide significance levels, as effect size of most neuropsychiatric disorders and complex traits related to those disorders are small and moderate. Hence, a convergent approach, which integrates multiple lines of evidence, seems to be a promising alternative to identify candidate genetic causalities for complex traits related to psychiatric disorders and perhaps to psychiatric disorders themselves. 42, 16 However, a further independent association study with a larger sample size will be needed to validate our finding and to detect associations for gene expression traits with low effect size. A large-scale meta-analysis will eventually lead to confirmation of true associations for cytoarchitectural traits.
Second, the cytoarchitectural markers used were cell type-specific, whereas the expression profiles were from the total gray matter of the PFC. Hence, in future studies, cell type-specific expression profiles may increase the sensitivity and specificity of studies designed to identify cis eSNPs associated with the cytoarchitectural abnormalities.
Third, although we used a linear regression model with covariates for the association analyses, we cannot rule out the possibility that unobserved covariates may have a significant role in the cytoarchitectural abnormalities and/or variation of expression profiles.
We identified candidate genes directly associated with the density of calbindin-containing GABAergic neurons and with the number of perineuronal oligodendrocytes in the PFC using a convergent analytical approach. We identified several candidate genes of neurodevelopment and apoptosis that are associated with these cytoarchitectural traits and consistent with our previous results. 3 In conclusion, neurodevelopmental deficits and aberrant apoptotic processes may contribute to the cytoarchitectural abnormalities of calbindin-containing GABAergic neurons and perineuronal oligodendrocytes, which are likely to be involved in the neuropathology of schizophrenia and bipolar disorder.
